HEALING WITHIN REACH
What Are HBOT Indications?
The Food and Drug Administration (FDA) has cleared hyperbaric chambers for certain medical uses, such as treating decompression sickness suffered by divers. Thirteen uses of a hyperbaric chamber for HBOT have been cleared by the FDA. They include treatment of air or gas embolism (dangerous “bubbles” in the bloodstream that obstruct circulation), carbon monoxide poisoning, decompression sickness (often known by divers as “the bends”), and thermal burns (caused by heat or fire).
The Undersea & Hyperbaric Medical Society is the reference source for HBO indications with established guidelines. The list is provided below and can also be viewed at the UHMS website.
1. Air or Gas Embolism
2. Carbon Monoxide Poisoning
3. Clostridial Myositis and Myonecrosis (Gas Gangrene)
4. Crush Injury, Compartment Syndrome and Other Acute Traumatic Ischemias
5. Decompression Sickness
6. Arterial Insufficiencies
7. Severe Anemia
8. Intracranial Abscess
9. Necrotizing Soft Tissue Infections
10. Osteomyelitis (Refractory)
11. Delayed Radiation Injury (Soft Tissue and Bony Necrosis)
12. Compromised Grafts and Flaps
13. Acute Thermal Burn Injury
14. Idiopathic Sudden Sensorineural Hearing Loss (approved on 10/8/2011 by UHMS Board of Directors)
International Accepted Indications
Research from around the world indicates that other conditions may benefit from hyperbaric oxygen therapy in conjunction with standard care, or when other measures have failed. In some instances, further double-blind, controlled studies are indicated. Many conditions may require integrative therapies, diagnostics, life style management, including optimized conventional treatment along with HBO therapy.
International research and clinical case examples have shown HBOT use in improving outcomes in other conditions such as chronic conditions that have inflammation as a primary and underlying pathophysiology and more.